fidarestat has been researched along with leupeptins in 1 studies
| Studies (fidarestat) | Trials (fidarestat) | Recent Studies (post-2010) (fidarestat) | Studies (leupeptins) | Trials (leupeptins) | Recent Studies (post-2010) (leupeptins) |
|---|---|---|---|---|---|
| 97 | 3 | 33 | 3,891 | 4 | 1,106 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ramana, KV; Saxena, A; Srivastava, SK; Tammali, R | 1 |
1 other study(ies) available for fidarestat and leupeptins
| Article | Year |
|---|---|
Aldose reductase inhibition prevents hypoxia-induced increase in hypoxia-inducible factor-1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) by regulating 26 S proteasome-mediated protein degradation in human colon cancer cells.
Topics: Aldehyde Reductase; Caco-2 Cells; Cell Hypoxia; Colonic Neoplasms; Cyclooxygenase 2; Cysteine Proteinase Inhibitors; Dinoprostone; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazolidines; Leupeptins; Matrix Metalloproteinase 2; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein-Lysine 6-Oxidase; Proto-Oncogene Proteins c-akt; RNA, Messenger; RNA, Neoplasm; Vascular Endothelial Growth Factor A; Vimentin | 2011 |